Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia.
GamEvac-Combi(一种异源 VSV 和 Ad5 载体埃博拉疫苗)的安全性和免疫原性:在俄罗斯健康成年人中进行的开放性 I/II 期试验
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2016.1238535
Dolzhikova I V, Zubkova O V, Tukhvatulin A I, Dzharullaeva A S, Tukhvatulina N M, Shcheblyakov D V, Shmarov M M, Tokarskaya E A, Simakova Y V, Egorova D A, Scherbinin D N, Tutykhina I L, Lysenko A A, Kostarnoy A V, Gancheva P G, Ozharovskaya T A, Belugin B V, Kolobukhina L V, Pantyukhov V B, Syromyatnikova S I, Shatokhina I V, Sizikova T V, Rumyantseva I G, Andrus A F, Boyarskaya N V, Voytyuk A N, Babira V F, Volchikhina S V, Kutaev D A, Bel'skih A N, Zhdanov K V, Zakharenko S M, Borisevich S V, Logunov D Y, Naroditsky B S, Gintsburg A L